# US 2010/0144812 A1 · Heterocyclic Sulfonamide Inhibitors of Beta Amyloid Production Containing an Azole

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0144812 A1
- Document ID: US20100144812A1
- Status: Published application
- Kind: A1
- Application number: 12/708,557
- Filed: 2010-02-19
- Published: 2010-06-10
- Earliest claimed: 2004-01-16
- Assignees: Wyeth
- Inventors: Lynn Resnick; Donna M. Huryn; Joan E. Sabalski; Joshua D. Berkowitz; Anthony Frank Kreft; Dennis Martin Kubrak; Thomas Joseph Caggiano; Koi Michele Morris
- Web page: https://patentgrep.com/patent/US20100144812A1

## CPC

- A61K 31/416: condensed with carbocyclic ring systems, e.g. indazole
- A61P 7/04: Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 9/14: Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- A61P 21/00: Drugs for disorders of the muscular or neuromuscular system
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D 231/12: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D 409/12: linked by a chain containing hetero atoms as chain links
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

Compounds useful for lowering beta amyloid levels are provided. The compounds have the structure of formula Ia: wherein, R1 is lower alkyl, substituted lower alkyl, phenyl, substituted phenyl, benzyl, substituted benzyl, benzyloxy, substituted benzyloxy, or SO2R5; R5 is phenyl, substituted phenyl, heterocycle, substituted heterocycle, alkyl, or substituted alkyl; R2 is lower alkyl, substituted lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, or cycloalkyl; R3 is hydrogen, lower alkyl, or substituted lower alkyl; R4 is phenyl, substituted phenyl, heterocycle, substituted heterocycle, thiophene, or substituted thiophene; R6 is hydrogen, lower alkyl, substituted lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, cycloalkyl, or substituted cycloalkyl; W, X and Y are independently CR7 or N; and R7 is hydrogen, halogen, lower alkyl, or substituted lower alkyl.

## Claims

### Claim 1

A method of inhibiting beta amyloid production in a subject, said method comprising delivering a pharmaceutical composition comprising a compound having the structure of formula (Ia), or a pharmaceutically acceptable salt, hydrate or prodrug thereof:
wherein:
R1 is selected from the group consisting of lower alkyl, substituted lower alkyl, phenyl, substituted phenyl, benzyl, substituted benzyl, benzyloxy, substituted benzyloxy, and SO2R5;
R5 is selected from the group consisting of phenyl, substituted phenyl, heterocycle, substituted heterocycle, alkyl, and substituted alkyl;
R2 is selected from the group consisting of lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, cycloalkyl, and substituted cycloalkyl;
R3 is selected from the group consisting of hydrogen, lower alkyl, and substituted lower alkyl;
R4 is selected from the group consisting of phenyl, substituted phenyl, heterocycle, and substituted heterocycle;
R6 is selected from the group consisting of hydrogen, lower alkyl, substituted lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, cycloalkyl, and substituted cycloalkyl;
W, X and Y are independently selected from the group consisting of CR7 and N; and
R7 is selected from the group consisting of hydrogen, halogen, lower alkyl, and substituted lower alkyl.

### Claim 2 (depends on 1)

The method according to claim 1, wherein said compound is:
5-Chloro-N-{2-ethyl-1-[1-(4-methoxybenzyl)-1H-pyrazol-5-yl]butyl}thiophene-2-sulfonamide;
4-Chloro-N-{2-ethyl-1-[1-(4-methoxybenzyl)-1H-pyrazol-5yl]butyl}benzenesulfonamide;
4-Bromo-N-{2-ethyl-1-[1-(4-methoxybenzyl)-1H-pyrazol-5-yl]butyl}benzenesulfonamide;
5-Chloro-N-{1-[1-(4-methoxybenzyl)-1H-pyrazol-5-yl]ethyl}thiophene-2-sulfonamide;
5-Chloro-N-{1-[1-(4-methoxybenzyl)-1H-pyrazol-5-yl]-2-methylpropyl}thiophene-2-sulfonamide;
5-Chloro-N-{1-[1-(4-methoxybenzyl)-1H-pyrazol-5-yl]butyl}thiophene-2-sulfonamide;
N-[1-(1-Butyl-1H-pyrazol-5-yl)-2-ethylbutyl]-5-chlorothiophene-2-sulfonamide;
5-Chloro-N-{2-ethyl-1-[1-(4-hydroxybenzyl)-1H-pyrazol-5-yl]butyl}thiophene-2-sulfonamide;
5-Chloro-N-(2-ethyl-1-{1-[(4-methylphenyl)sulfonyl]-1H-pyrazol-5-yl}butyl)thiophene-2-sulfonamide;
5-Chloro-N-{2-ethyl-1-[1-(4-methoxyphenyl)-1H-pyrazol-5-yl]butyl}thiophene-2-sulfonamide;
5-Chloro-N-{2-ethyl-1-[1-(4-hydroxyphenyl)-1H-pyrazol-5-yl]butyl}thiophene-2-sulfonamide;
5-Chloro-N-[2-methyl-1-(1-phenyl-1H-pyrazol-5-yl)propyl]thiophene-2-sulfonamide;
5-Chloro-N-[1-(1-phenyl-1H-pyrazol-5-yl)ethyl]thiophene-2-sulfonamide;
5-Chloro-N-{2-methyl-1-[1-(4-methylphenyl)-1H-pyrazol-5-yl]propyl}thiophene-2-sulfonamide;
5-Chloro-N-{1-[1-(4-fluorophenyl)-1H-pyrazol-5-yl]-2-methylpropyl}thiophene-2-sulfonamide;
5-Chloro-N-{2-methyl-1-[1-(3-methylphenyl)-1H-pyrazol-5-yl]propyl}thiophene-2-sulfonamide;
5-Chloro-N-[2-ethyl-1-(1-phenyl-1H-pyrazol-5-yl)butyl]thiophene-2-sulfonamide;
5-Chloro-N-(2-ethyl-1-{1-[4-(trifluoromethyl)phenyl]-1H-pyrazol-5-yl}butyl)thiophene-2-sulfonamide;
5-Chloro-N-{2-ethyl-1-[1-(4-fluorobenzyl)-1H-1,2,4-triazol-5-yl]butyl}thiophene-2-sulfonamide;
5-Chloro-N-(2-ethyl-1-{1-[4-(trifluoromethoxy)benzyl]-1H-1,2,4-triazol-5-yl}butyl)thiophene-2-sulfonamide;
5-Chloro-N-{2-ethyl-1-[1-(4-methoxybenzyl)-1H-1,2,4-triazol-5-yl]butyl}thiophene-2-sulfonamide;
N-[1-(1-Benzyl-1H-1,2,4-triazol-5-yl)-2-ethylbutyl]-5-chlorothiophene-2-sulfonamide;
N-[1-(1-Benzyl-1H-1,2,4-triazol-5-yl)-2-methylpropyl]-5-chlorothiophene-2-sulfonamide;
5-Chloro-N-{2-methyl-1-[1-(4-methylbenzyl)-1H-1,2,4-triazol-5-yl]propyl}thiophene-2-sulfonamide;
N-[1-(1-Benzyl-1H-1,2,4-triazol-5-yl)ethyl]-5-chlorothiophene-2-sulfonamide;
5-Chloro-N-{1-[1-(4-methylbenzyl)-1H-1,2,4-triazol-5-yl]ethyl}thiophene-2-sulfonamide;
5-Chloro-N-{2-ethyl-1-[1-(4-methylbenzyl)-1H-1,2,4-triazol-5-yl]butyl}thiophene-2-sulfonamide;
N-[1-(1-Benzyl-1H-imidazol-2-yl)-2-ethylbutyl]-5-chlorothiophene-2-sulfonamide;
5-Chloro-N-{2-ethyl-1-[1-(4-methoxybenzyl)-1H-imidazol-2-yl]butyl}thiophene-2-sulfonamide;
5-Chloro-N-{2-ethyl-1-[1-(4-hydroxybenzyl)-1H-imidazol-2-yl]butyl}thiophene-2-sulfonamide;
N-[1-(1-Benzyl-1H-pyrrol-2-yl)-2-methylpropyl]-5-chlorothiophene-2-sulfonamide;
5-Chloro-N-{1-[1-(4-methoxybenzyl)-1H-pyrrol-2-yl]-2-methylpropyl}thiophene-2-sulfonamide;
N-{1-[1-(Benzyloxy)-1H-pyrazol-5-yl]-2-ethylbutyl}-5-chlorothiophene-2-sulfonamide;
5-Chloro-N-{(4-fluorophenyl)[1-(4-fluorophenyl)-1H-pyrazol-5-yl]methyl}thiophene-2-sulfonamide;
5-Chloro-N-{1-[1-(4-fluorophenyl)-1H-pyrazol-5-yl]-2-phenylethyl}thiophene-2-sulfonamide;
4-Chloro-N-[2-ethyl-1-(1-phenyl-1H-pyrazol-5-yl)butyl]benzenesulfonamide;
4-Cyano-N-[2-ethyl-1-(1-phenyl-1H-pyrazol-5-yl)butyl]benzenesulfonamide;
4,5-Dichloro-N-[2-ethyl-1-(1-phenyl-1H-pyrazol-5-yl)butyl]thiophene-2-sulfonamide;
3,4-Dichloro-N-[2-ethyl-1-(1-phenyl-1H-pyrazol-5-yl)butyl]benzenesulfonamide;
5-Bromo-N-[2-ethyl-1-(1-phenyl-1H-pyrazol-5-yl)butyl]thiophene-2-sulfonamide;
5-Chloro-N-{(1R)-1-[1-(4-fluorophenyl)-1H-pyrazol-5-yl]-2-methylpropyl}thiophene-2-sulfonamide;
5-Chloro-N-{(1S)-1-[1-(4-fluorophenyl)-1H-pyrazol-5-yl]-2-methylpropyl}thiophene-2-sulfonamide;
4-Cyano-N-[2-ethyl-1-(1-phenyl-1H-pyrazol-5-yl)butyl]-N-methylbenzenesulfonamide;
4-Chloro-N-[2-ethyl-1-(1-phenyl-1H-pyrazol-5-yl)butyl]-N-methylbenzenesulfonamide;
4,5-Dichloro-N-[2-ethyl-1-(1-phenyl-1H-pyrazol-5-yl)butyl]-N-methylthiophene-2-sulfonamide;
5-Chloro-N-[2-ethyl-1-(1-phenyl-1H-pyrazol-5-yl)butyl]-N-methylthiophene-2-sulfonamide;
3,4-Dichloro-N-[2-ethyl-1-(1-phenyl-1H-pyrazol-5-yl)butyl]-N-methylbenzenesulfonamide; or
5-Bromo-N-[2-ethyl-1-(1-phenyl-1H-pyrazol-5-yl)butyl]-N-methylthiophene-2-sulfonamide.

### Claim 3 (depends on 1)

The method according to claim 1, wherein R1 is substituted benzyl.

### Claim 4 (depends on 1)

The method according to claim 1, wherein R1 is substituted phenyl.

### Claim 5 (depends on 1)

The method according to claim 1, wherein R2 is lower alkyl.

### Claim 6 (depends on 1)

The method according to claim 1, wherein R3 is hydrogen.

### Claim 7 (depends on 1)

The method according to claim 1, wherein R4 is thiophene or substituted thiophene.

### Claim 8 (depends on 7)

The method according to claim 7, wherein R4 is 5-chloro-2-thiophene.

### Claim 9 (depends on 1)

The method according to claim 1, wherein R6 is H.

### Claim 10

A method of treating a disease selected from the group consisting of Alzheimer's Disease, amyloid angiopathy, cerebral amyloid angiopathy, systemic amyloidosis, hereditary cerebral hemorrhage with amyloidosis of the Dutch type, inclusion body myositis, mild cognitive impairment (MCI) and Down's syndrome, in a subject, said method comprising administering a compound of formula Ia to said subject in an amount sufficient to alleviate the symptoms or progress of said disease, wherein said compound of formula (Ia) or a pharmaceutically acceptable salt, hydrate or prodrug thereof, is selected from the group consisting of (a) and (b)
(a) a compound of the structure:
wherein:
R1 is selected from the group consisting of lower alkyl, substituted lower alkyl, phenyl, substituted phenyl, benzyl, substituted benzyl, benzyloxy, substituted benzyloxy, and SO2R5;
R5 is selected from the group consisting of phenyl, substituted phenyl, heterocycle, substituted heterocycle, alkyl, and substituted alkyl;
R2 is selected from the group consisting of lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, cycloalkyl, and substituted cycloalkyl;
R3 is selected from the group consisting of hydrogen, lower alkyl, and substituted lower alkyl;
R4 is selected from the group consisting of phenyl, substituted phenyl, heterocycle, and substituted heterocycle;
R6 is selected from the group consisting of hydrogen, lower alkyl, substituted lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, cycloalkyl, and substituted cycloalkyl;
W, X and Y are independently selected from the group consisting of CR7 and N; and
R7 is selected from the group consisting of hydrogen, halogen, lower alkyl, and substituted lower alkyl; and
(b) a compound of the structure:
wherein:
R1 is selected from the group consisting of lower alkyl, substituted lower alkyl, phenyl, substituted phenyl, benzyl, substituted benzyl, benzyloxy, substituted benzyloxy, and SO2R5;
R5 is selected from the group consisting of phenyl, substituted phenyl, heterocycle, substituted heterocycle, alkyl, and substituted alkyl;
R2 is selected from the group consisting of lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, cycloalkyl, and substituted cycloalkyl;
R3 is selected from the group consisting of hydrogen, lower alkyl, and substituted lower alkyl;
R4 is selected from the group consisting of phenyl, substituted phenyl, heterocycle, and substituted heterocycle;
R6 is selected from the group consisting of hydrogen, lower alkyl, substituted lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, cycloalkyl, and substituted cycloalkyl;
W, X and Y are independently selected from the group consisting of CR7 and N; and
R7 is selected from the group consisting of hydrogen, halogen, lower alkyl, and substituted lower alkyl.

### Claim 11 (depends on 10)

The method according to claim 10, wherein said compound is:
5-Chloro-N-{2-ethyl-1-[1-(4-methoxybenzyl)-1H-pyrazol-5-yl]butyl}thiophene-2-sulfonamide;
4-Chloro-N-{2-ethyl-1-[1-(4-methoxybenzyl)-1H-pyrazol-5yl]butyl}benzenesulfonamide;
4-Bromo-N-{2-ethyl-1-[1-(4-methoxybenzyl)-1H-pyrazol-5-yl]butyl}benzenesulfonamide;
5-Chloro-N-{1-[1-(4-methoxybenzyl)-1H-pyrazol-5-yl]ethyl}thiophene-2-sulfonamide;
5-Chloro-N-{1-[1-(4-methoxybenzyl)-1H-pyrazol-5-yl]-2-methylpropyl}thiophene-2-sulfonamide;
5-Chloro-N-{1-[1-(4-methoxybenzyl)-1H-pyrazol-5-yl]butyl}thiophene-2-sulfonamide;
N-[1-(1-Butyl-1H-pyrazol-5-yl)-2-ethylbutyl]-5-chlorothiophene-2-sulfonamide;
5-Chloro-N-{2-ethyl-1-[1-(4-hydroxybenzyl)-1H-pyrazol-5-yl]butyl}thiophene-2-sulfonamide;
5-Chloro-N-(2-ethyl-1-{1-[(4-methylphenyl)sulfonyl]-1H-pyrazol-5-yl}butyl)thiophene-2-sulfonamide;
5-Chloro-N-{2-ethyl-1-[1-(4-methoxyphenyl)-1H-pyrazol-5-yl]butyl}thiophene-2-sulfonamide;
5-Chloro-N-{2-ethyl-1-[1-(4-hydroxyphenyl)-1H-pyrazol-5-yl]butyl}thiophene-2-sulfonamide;
5-Chloro-N-[2-methyl-1-(1-phenyl-1H-pyrazol-5-yl)propyl]thiophene-2-sulfonamide;
5-Chloro-N-[1-(1-phenyl-1H-pyrazol-5-yl)ethyl]thiophene-2-sulfonamide;
5-Chloro-N-{2-methyl-1-[1-(4-methylphenyl)-1H-pyrazol-5-yl]propyl}thiophene-2-sulfonamide;
5-Chloro-N-{1-[1-(4-fluorophenyl)-1H-pyrazol-5-yl]-2-methylpropyl}thiophene-2-sulfonamide;
5-Chloro-N-{2-methyl-1-[1-(3-methylphenyl)-1H-pyrazol-5-yl]propyl}thiophene-2-sulfonamide;
5-Chloro-N-[2-ethyl-1-(1-phenyl-1H-pyrazol-5-yl)butyl]thiophene-2-sulfonamide;
5-Chloro-N-(2-ethyl-1-{1-[4-(trifluoromethyl)phenyl]-1H-pyrazol-5-yl}butyl)thiophene-2-sulfonamide;
5-Chloro-N-{2-ethyl-1-[1-(4-fluorobenzyl)-1H-1,2,4-triazol-5-yl]butyl}thiophene-2-sulfonamide;
5-Chloro-N-(2-ethyl-1-{1-[4-(trifluoromethoxy)benzyl]-1H-1,2,4-triazol-5-yl}butyl)thiophene-2-sulfonamide;
5-Chloro-N-{2-ethyl-1-[1-(4-methoxybenzyl)-1H-1,2,4-triazol-5-yl]butyl}thiophene-2-sulfonamide;
N-[1-(1-Benzyl-1H-1,2,4-triazol-5-yl)-2-ethylbutyl]-5-chlorothiophene-2-sulfonamide;
N-[1-(1-Benzyl-1H-1,2,4-triazol-5-yl)-2-methylpropyl]-5-chlorothiophene-2-sulfonamide;
5-Chloro-N-{2-methyl-1-[1-(4-methylbenzyl)-1H-1,2,4-triazol-5-yl]propyl}thiophene-2-sulfonamide;
N-[1-(1-Benzyl-1H-1,2,4-triazol-5-yl)ethyl]-5-chlorothiophene-2-sulfonamide;
5-Chloro-N-{1-[1-(4-methylbenzyl)-1H-1,2,4-triazol-5-yl]ethyl}thiophene-2-sulfonamide;
5-Chloro-N-{2-ethyl-1-[1-(4-methylbenzyl)-1H-1,2,4-triazol-5-yl]butyl}thiophene-2-sulfonamide;
N-[1-(1-Benzyl-1H-imidazol-2-yl)-2-ethylbutyl]-5-chlorothiophene-2-sulfonamide;
5-Chloro-N-{2-ethyl-1-[1-(4-methoxybenzyl)-1H-imidazol-2-yl]butyl}thiophene-2-sulfonamide;
5-Chloro-N-{2-ethyl-1-[1-(4-hydroxybenzyl)-1H-imidazol-2-yl]butyl}thiophene-2-sulfonamide;
N-[1-(1-Benzyl-1H-pyrrol-2-yl)-2-methylpropyl]-5-chlorothiophene-2-sulfonamide;
5-Chloro-N-{1-[1-(4-methoxybenzyl)-1H-pyrrol-2-yl]-2-methylpropyl}thiophene-2-sulfonamide;
N-{1-[1-(Benzyloxy)-1H-pyrazol-5-yl]-2-ethylbutyl}-5-chlorothiophene-2-sulfonamide;
5-Chloro-N-{(4-fluorophenyl)[1-(4-fluorophenyl)-1H-pyrazol-5-yl]methyl}thiophene-2-sulfonamide;
5-Chloro-N-{1-[1-(4-fluorophenyl)-1H-pyrazol-5-yl]-2-phenylethyl}thiophene-2-sulfonamide;
4-Chloro-N-[2-ethyl-1-(1-phenyl-1H-pyrazol-5-yl)butyl]benzenesulfonamide;
4-Cyano-N-[2-ethyl-1-(1-phenyl-1H-pyrazol-5-yl)butyl]benzenesulfonamide;
4,5-Dichloro-N-[2-ethyl-1-(1-phenyl-1H-pyrazol-5-yl)butyl]thiophene-2-sulfonamide;
3,4-Dichloro-N-[2-ethyl-1-(1-phenyl-1H-pyrazol-5-yl)butyl]benzenesulfonamide;
5-Bromo-N-[2-ethyl-1-(1-phenyl-1H-pyrazol-5-yl)butyl]thiophene-2-sulfonamide;
5-Chloro-N-{(1R)-1-[1-(4-fluorophenyl)-1H-pyrazol-5-yl]-2-methylpropyl}thiophene-2-sulfonamide;
5-Chloro-N-{(1S)-1-[1-(4-fluorophenyl)-1H-pyrazol-5-yl]-2-methylpropyl}thiophene-2-sulfonamide;
4-Cyano-N-[2-ethyl-1-(1-phenyl-1H-pyrazol-5-yl)butyl]-N-methylbenzenesulfonamide;
4-Chloro-N-[2-ethyl-1-(1-phenyl-1H-pyrazol-5-yl)butyl]-N-methylbenzenesulfonamide;
4,5-Dichloro-N-[2-ethyl-1-(1-phenyl-1H-pyrazol-5-yl)butyl]-N-methylthiophene-2-sulfonamide;
5-Chloro-N-[2-ethyl-1-(1-phenyl-1H-pyrazol-5-yl)butyl]-N-methylthiophene-2-sulfonamide;
3,4-Dichloro-N-[2-ethyl-1-(1-phenyl-1H-pyrazol-5-yl)butyl]-N-methylbenzenesulfonamide; or
5-Bromo-N-[2-ethyl-1-(1-phenyl-1H-pyrazol-5-yl)butyl]-N-methylthiophene-2-sulfonamide.

### Claim 12 (depends on 10)

The method according to claim 10, wherein R1 is substituted benzyl.

### Claim 13 (depends on 10)

The method according to claim 10, wherein R1 is substituted phenyl.

### Claim 14 (depends on 10)

The method according to claim 10, wherein R2 is lower alkyl.

### Claim 15 (depends on 10)

The method according to claim 10, wherein R3 is hydrogen.

### Claim 16 (depends on 10)

The method according to claim 10, wherein R4 is thiophene or substituted thiophene.

### Claim 17 (depends on 10)

The method according to claim 10, wherein R4 is 5-chloro-2-thiophene.

### Claim 18 (depends on 10)

The method according to claim 10, wherein R6 is H.

### Claim 19

A compound of formula (Ia), which is selected from the group consisting of (a), (b), (c), (d), and (e):
(a) a compound wherein:
R1 is selected from the group consisting of lower alkyl, substituted lower alkyl, phenyl, substituted phenyl, benzyl, substituted benzyl, benzyloxy, substituted benzyloxy, and SO2R5;
R5 is selected from the group consisting of phenyl, substituted phenyl, heterocycle, substituted heterocycle, alkyl, and substituted alkyl;
R2 is selected from the group consisting of lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, cycloalkyl, and substituted cycloalkyl;
R3 is selected from the group consisting of hydrogen, lower alkyl, and substituted lower alkyl;
R4 is phenyl or substituted phenyl;
R6 is selected from the group consisting of hydrogen, lower alkyl, substituted lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, cycloalkyl, and substituted cycloalkyl;
W is N;
X and Y are CR7; and
R7 is selected from the group consisting of hydrogen, halogen, lower alkyl, and substituted lower alkyl;
(b) a compound, wherein:
R1 is selected from the group consisting of lower alkyl, substituted lower alkyl, phenyl, substituted phenyl, benzyl, substituted benzyl, benzyloxy, substituted benzyloxy, and SO2R5;
R5 is selected from the group consisting of phenyl, substituted phenyl, heterocycle, substituted heterocycle, alkyl, and substituted alkyl;
R2 is selected from the group consisting of lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, cycloalkyl, and substituted cycloalkyl;
R3 is hydrogen;
R4 is phenyl or substituted phenyl;
R6 is selected from the group consisting of hydrogen, lower alkyl, substituted lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, cycloalkyl, and substituted cycloalkyl;
W is N;
X and Y are CR7; and
R7 is selected from the group consisting of hydrogen, halogen, lower alkyl, and substituted lower alkyl;
(c) a compound, wherein:
R1 is selected from the group consisting of lower alkyl, substituted lower alkyl, phenyl, substituted phenyl, benzyl, substituted benzyl, benzyloxy, substituted benzyloxy, and SO2R5;
R5 is selected from the group consisting of phenyl, substituted phenyl, heterocycle, substituted heterocycle, alkyl, and substituted alkyl;
R2 is selected from the group consisting of lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, cycloalkyl, and substituted cycloalkyl;
R3 is selected from the group consisting of hydrogen, lower alkyl, and substituted lower alkyl;
R4 is phenyl or substituted phenyl;
R6 is selected from the group consisting of hydrogen, lower alkyl, substituted lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, cycloalkyl, and substituted cycloalkyl;
W is N;
X is CR7 and R7 is selected from the group consisting of hydrogen, halogen, lower alkyl, and substituted lower alkyl;
Y is CR7 and R7 is halogen;
(d) a compound, wherein:
R1 is lower alkyl or substituted lower alkyl;
R2 is selected from the group consisting of lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, cycloalkyl, and substituted cycloalkyl;
R3 is selected from the group consisting of hydrogen, lower alkyl, and substituted lower alkyl;
R4 is phenyl or substituted phenyl;
R6 is selected from the group consisting of hydrogen, lower alkyl, substituted lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, cycloalkyl, and substituted cycloalkyl;
W is N;
X and Y are CR7; and
R7 is selected from the group consisting of hydrogen, halogen, lower alkyl, and substituted lower alkyl; and
(e) a compound, wherein:
R1 is selected from the group consisting of lower alkyl, substituted lower alkyl, phenyl, substituted phenyl, benzyl, substituted benzyl, benzyloxy, substituted benzyloxy, and SO2R5;
R5 is selected from the group consisting of phenyl, substituted phenyl, heterocycle, substituted heterocycle, alkyl, and substituted alkyl;
R2 is selected from the group consisting of lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, cycloalkyl, and substituted cycloalkyl;
R3 is selected from the group consisting of hydrogen, lower alkyl, and substituted lower alkyl;
R4 is phenyl or substituted phenyl;
R6 is hydrogen;
W is N;
X and Y are CR7; and
R7 is selected from the group consisting of hydrogen, halogen, lower alkyl, and substituted lower alkyl.
